|
Drug Description
Description
Humulin is synthesized in a non-disease-producing special laboratory strain of Escherichia coli bacteria that has been genetically altered by the addition of the human gene for insulin production. Humulin 70/ 30 is a mixture of 70% Human Insulin Isophane Suspension and 30% Human Insulin Injection. It is an intermediate-acting insulin combined with the more rapid onset of action of regular insulin. Text Continues Below
The duration of activity may last up to 24 hours following injection. The time course of action of any insulin may vary considerably in different individuals or at different times in the same individual. As with all insulin preparations, the duration of action of Humulin 70/ 30 is dependent on dose, site of injection, blood supply, temperature, and physical activity. Humulin 70/ 30 is a sterile suspension and is for subcutaneous injection only. It should not be used intravenously or intramuscularly. The concentration of Humulin 70/ 30 in the Humulin 70/ 30 Pen is 100 units/ mL (U-100). Identification Humulin disposable insulin delivery devices, manufactured by Eli Lilly and Company, are available in 2 formulations — NPH and 70/ 30. Your doctor has prescribed the type of insulin that he/ she believes is best for you. DO NOT USE ANY OTHER INSULIN EXCEPT ON HIS/ HER ADVICE AND DIRECTION. The Humulin 70/ 30 Pen is available in boxes of 5 disposable insulin delivery devices (" insulin pens"). The Humulin 70/ 30 Pen is not designed to allow any other insulin to be mixed in its cartridge, or for the cartridge to be removed. Always examine the appearance of Humulin 70/ 30 suspension in the insulin pen before administering a dose. A cartridge of Humulin 70/ 30 contains a small glass bead to assist in mixing. Humulin 70/ 30 Pen must be rolled between the palms 10 times and inverted 180° 10 times before each injection so that the contents are uniformly mixed (see Figures 1 and 2). Inspect the Humulin 70/ 30 suspension for uniform mixing and repeat the above steps as necessary.
|
